“…1 Although data suggest that patients taking aspirin, warfarin, or clopidogrel may be at slightly higher risk of minor bleeding from cutaneous surgery, these agents have not been associated with severe life-threatening hemorrhagic complications after cutaneous surgery. 2,3 In contrast, perioperative discontinuation of medically necessary aspirin and warfarin during cutaneous surgery has been associated with severe thrombotic complications (e.g., cerebrovascular accidents, transient ischemic attacks, myocardial infarctions, deep venous thromboses [DVT], pulmonary embolism [PE], retinal artery occlusion leading to blindness, and death). 4,5 The morbidity and magnitude of the potential hemorrhagic complications pale in comparison with these potential thrombotic events.…”